Recent News Articles
Uganda loses more than US$1.1billion annually due ...Read More
In this report, we profile the work of renown Make...Read More
Prevention of infectious diseases in beef cattle t...Read More
Ugandan farmers who could switch up their herd to ...Read More
December 15, 2022 at 2:01 pm by Admin
Ticks are among the most important vectors of pathogens that cause some of the most devastating tick-borne diseases (TBDs) in the livestock sector in eastern Africa, resulting in loss of productivity and mortalities. They are among the leading causative agents of diseases in cattle. East Coast Fever for instance causes up to 100% mortalities in untreated exotic European breeds and their crosses. It also contributes 30% losses in calves of local zebu cattle, which depletes the stock for replacement of the national herd. Ticks are vectors of tick-borne pathogens and their control is by acaricides. For livestock farmers, the present methods of tick control using acaricides, have become costly and ineffective due to increasing acaricide tick resistance. This discourages investment in the livestock sector and can lead to food insecurity, thereby impacting on the economy. Alternative methods that reduce the use of acaricides and protect cattle from the risk of tick-borne diseases are urgently needed.
The Anti-Tick Vaccine Development Initiative is at the forefront of research to deliver an innovative alternative immunological solution that advances the prevention and treatment of one of Uganda’s most challenging livestock problems: tick-borne diseases. We are the makers of TicVac-U®, the first anti-tick vaccine researched, developed and manufactured in Uganda.Read more
Working together with the Government of Uganda, Makerere University, College of Veterinary Medicine, Animal Resources and Bio-security (COVAB), National Drug Authority (NDA) and other stakeholders, our vision is to eradicate the problems of ticks in Uganda first, then globally, working towards a tick free world.
Our mission is to contribute to the control of ticks and tick-borne diseases by offering innovative alternative immunological control, research, manufacture and distribution of critical veterinary vaccines that will make a positive difference to Uganda’s livestock, the people that depend on them and the country’s economy.
Dr. Margaret Saimo-Kahwa
B.VetMed, Msc, PhD. Principle Investigator, Anti-Tick Vaccine Development Initiative. Senior Lecturer at the College of Veterinary Medicine, Animal Resources and Bio-security (COVAB).View Details
Dr. Kokas Ikwap
BVM, MSc in Molecular Biology & Biotechnology. Scientist/Parasitologist at the TicVac Anti-Tick Vaccine Development Initiative.View Details
Dr. William Olaho Mukani
BVM, MSc, PhD in Veterinary Pathology and Microbiology. Dr Olaho is Project Coordinator at IAU-IBAR and a Consultant/Immunologist at the TicVac Anti-Tick Vaccine Development Initiative.View Details
Dr. Herbert Mukiibi
Dip AH, BVM, MSC in Epidemiology. Lecturer at the College of Veterinary Medicine, Animal Resources and Bio-security (COVAB). Scientist at the TicVac Anti-Tick Vaccine Development Initiative.View Details
Mr. Peregrine Sebulime
BVM, Msc in Biological Sciences. Lecturer, Department of Wildlife and Aquatic Animal Resources, MAK. Scientist at the TicVac Anti-Tick Vaccine Development Initiative.View Details
Mr. David Kalenzi Atuhaire
BVM, MSc, PhD in Veterinary Medicine . Mr Atuhaire is a Consultant at the TicVac Anti-Tick Vaccine Development Initiative, working on Quality Control protocols for Vaccine Production.View Details